Gyre Therapeutics Inc (GYRE) - News Archive

In a landmark achievement recently reported by Gyre Therapeutics Inc. (NASDAQ: GYRE), the company s lead candidate, Hydronidone, has successfully met its primary endpoint in a pivotal Phase 3 trial aimed at treating chr...

Gyre Therapeutics, a pioneering biopharmaceutical company at the forefront of addressing complex medical challenges, has reached significant milestones in its quest for innovative healthcare solutions. In a decisive mov...

Gyre Therapeutics Gains NMPA Approval, Marking a Milestone for Treating CLD-Associated Thrombocytopenia in ChinaGyre Therapeutics Announces China s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-...

Gyre Pharmaceuticals, a leading global pharmaceutical company, has recently achieved a significant milestone in its quest to combat the debilitating condition of Pulmonary Arterial Hypertension (PAH). The company has re...

In a groundbreaking move, Gyre Therapeutics, a pioneering biotech company dedicated to advancing treatments for neurological disorders, has announced the expansion of its esteemed Board of Directors through the appointm...